Vontobel Holding’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,741
| Closed | -$434K | – | 1118 |
|
|
2025
Q1 | $434K | Sell |
12,741
-2,327
| -15% | -$79.2K | ﹤0.01% | 827 |
|
|
2024
Q4 | $593K | Sell |
15,068
-1,889
| -11% | -$74.4K | ﹤0.01% | 749 |
|
|
2024
Q3 | $797K | Buy |
16,957
+600
| +4% | +$28.2K | ﹤0.01% | 652 |
|
|
2024
Q2 | $883K | Sell |
16,357
-1,450
| -8% | -$78.3K | ﹤0.01% | 595 |
|
|
2024
Q1 | $1.21M | Sell |
17,807
-47
| -0.3% | -$3.2K | 0.01% | 531 |
|
|
2023
Q4 | $1.12M | Sell |
17,854
-549
| -3% | -$34.4K | 0.01% | 564 |
|
|
2023
Q3 | $835K | Sell |
18,403
-497
| -3% | -$22.6K | 0.01% | 625 |
|
|
2023
Q2 | $1.06M | Buy |
18,900
+249
| +1% | +$14K | 0.01% | 587 |
|
|
2023
Q1 | $844K | Sell |
18,651
-2,681
| -13% | -$121K | 0.01% | 631 |
|
|
2022
Q4 | $836K | Buy |
21,332
+2,643
| +14% | +$104K | 0.01% | 617 |
|
|
2022
Q3 | $1.22M | Sell |
18,689
-1,566
| -8% | -$102K | 0.01% | 503 |
|
|
2022
Q2 | $1.28M | Sell |
20,255
-1,105
| -5% | -$69.6K | 0.01% | 486 |
|
|
2022
Q1 | $1.37M | Sell |
21,360
-5,119
| -19% | -$328K | 0.01% | 534 |
|
|
2021
Q4 | $2.09M | Buy |
26,479
+4,664
| +21% | +$368K | 0.02% | 426 |
|
|
2021
Q3 | $2.44M | Buy |
21,815
+3,144
| +17% | +$352K | 0.02% | 406 |
|
|
2021
Q2 | $2.81M | Buy |
+18,671
| New | +$2.81M | 0.02% | 372 |
|